<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">30669993</PMID><DateCompleted><Year>2019</Year><Month>08</Month><Day>01</Day></DateCompleted><DateRevised><Year>2020</Year><Month>12</Month><Day>09</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2172</ISSN><JournalIssue CitedMedium="Internet"><Volume>20</Volume><Issue>1</Issue><PubDate><Year>2019</Year><Month>Jan</Month><Day>22</Day></PubDate></JournalIssue><Title>BMC immunology</Title><ISOAbbreviation>BMC Immunol</ISOAbbreviation></Journal><ArticleTitle>Monoclonal antibody against EV71 3D<sup>pol</sup> inhibits the polymerase activity of RdRp and virus replication.</ArticleTitle><Pagination><StartPage>6</StartPage><MedlinePgn>6</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">6</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12865-019-0288-x</ELocationID><Abstract><AbstractText Label="BACKGROUND">Enterovirus A 71 (EV71) is a neurotropic virus that may lead to acute flaccid paralysis, encephalitis, cardiopulmonary failure or even death. No vaccine and defensive drug controlling EV71 is currently available, novel and efficient antiviral drug or vaccine is therefore urgently needed. 3D<sup>pol</sup> (RNA-dependent RNA polymerase (RdRp)) has been an important target for anti-EV71 drug development.</AbstractText><AbstractText Label="METHODS">A panel of monoclonal IgG antibodies (mAbs) against EV71 3D<sup>pol</sup> were generated by traditional cell fusion methods. And the antibody affinity and specificity to EV71 3D<sup>pol</sup> were evaluated by Enzyme-linked Immunosorbent Assay (ELISA), Indirect Fluorescent Assay (IFA) and Western blotting. Antiviral activities of these antibodies were also determined in vitro and in vivo.</AbstractText><AbstractText Label="RESULTS">Two mAbs towards EV71 3D<sup>pol</sup> were able to effectively suppress EV71 replication in Vero-1008 cell when intracellarly delivered. And they also dampened the RNA polymerase activity of 3D<sup>pol</sup> in vitro. More importantly, these mAbs provided partial protection in EV71-challenged neonatal murine challenge model.</AbstractText><AbstractText Label="CONCLUSIONS">These results showed that two of mAbs against EV71 3D<sup>pol</sup> inhibited EV71 replication and could be utilized as promising therapeutic drug candidate.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Yaoming</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Mucosal Immunity Research Group, State Key Laboratory of Virology, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, 430071, People's Republic of China. liym@whsw.edu.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Jie</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Mucosal Immunity Research Group, State Key Laboratory of Virology, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, 430071, People's Republic of China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Chinese Academy of Sciences, Beijing, 100049, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qi</LastName><ForeName>Xiuwen</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Mucosal Immunity Research Group, State Key Laboratory of Virology, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, 430071, People's Republic of China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Chinese Academy of Sciences, Beijing, 100049, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yan</LastName><ForeName>Huimin</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Mucosal Immunity Research Group, State Key Laboratory of Virology, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, 430071, People's Republic of China. hmyan@wh.iov.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>01</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Immunol</MedlineTA><NlmUniqueID>100966980</NlmUniqueID><ISSNLinking>1471-2172</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000911">Antibodies, Monoclonal</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007074">Immunoglobulin G</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.7.48</RegistryNumber><NameOfSubstance UI="D012324">RNA-Dependent RNA Polymerase</NameOfSubstance></Chemical></ChemicalList><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000911" MajorTopicYN="N">Antibodies, Monoclonal</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000918" MajorTopicYN="N">Antibody Specificity</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001665" MajorTopicYN="N">Binding Sites</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="N">Enterovirus A, Human</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="N">Enterovirus Infections</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007074" MajorTopicYN="N">Immunoglobulin G</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011485" MajorTopicYN="N">Protein Binding</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012324" MajorTopicYN="N">RNA-Dependent RNA Polymerase</DescriptorName><QualifierName UI="Q000037" MajorTopicYN="Y">antagonists &amp; inhibitors</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014779" MajorTopicYN="N">Virus Replication</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Antiviral</Keyword><Keyword MajorTopicYN="N">Enterovirus a 71</Keyword><Keyword MajorTopicYN="N">Monoclonal antibody</Keyword><Keyword MajorTopicYN="N">RdRp</Keyword></KeywordList><CoiStatement>ETHICS APPROVAL: Animal studies were performed according to Regulations for the Administration of Affairs Concerning Experimental Animals in China (1988), and the Guidelines for Animal Care and Use, the ethics committee of life science and research in Wuhan Institute of Virology (WIV), Chinese Academy of Sciences (CAS) (permit number WIVA09201502 and WIVA09201504). CONSENT FOR PUBLICATION: All the authors have read and approved the paper for publication. COMPETING INTERESTS: All authors declare that they have no conflicts of interest. PUBLISHER&#x2019;S NOTE: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>6</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>1</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>1</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>1</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>8</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2019</Year><Month>1</Month><Day>22</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30669993</ArticleId><ArticleId IdType="pmc">PMC6343263</ArticleId><ArticleId IdType="doi">10.1186/s12865-019-0288-x</ArticleId><ArticleId IdType="pii">10.1186/s12865-019-0288-x</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>McMinn P, Stratov I, Nagarajan L, Davis S. Neurological manifestations of enterovirus 71 infection in children during an outbreak of hand, foot, and mouth disease in Western Australia. Clin Infect Dis. 2001;32(2):236&#x2013;242. doi: 10.1086/318454.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/318454</ArticleId><ArticleId IdType="pubmed">11170913</ArticleId></ArticleIdList></Reference><Reference><Citation>Chua KB, Kasri AR. Hand foot and mouth disease due to enterovirus 71 in Malaysia. Virol Sin. 2011;26(4):221&#x2013;228. doi: 10.1007/s12250-011-3195-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12250-011-3195-8</ArticleId><ArticleId IdType="pmc">PMC8222466</ArticleId><ArticleId IdType="pubmed">21847753</ArticleId></ArticleIdList></Reference><Reference><Citation>Thibaut HJ, De Palma AM, Neyts J. Combating enterovirus replication: state-of-the-art on antiviral research. Biochem Pharmacol. 2012;83(2):185&#x2013;192. doi: 10.1016/j.bcp.2011.08.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bcp.2011.08.016</ArticleId><ArticleId IdType="pubmed">21889497</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun Y, Wang Y, Shan C, Chen C, Xu P, Song M, Zhou H, Yang C, Xu W, Shi PY, et al. Enterovirus 71 VPg uridylation uses a two-molecular mechanism of 3D polymerase. J Virol. 2012;86(24):13662&#x2013;13671. doi: 10.1128/JVI.01712-12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01712-12</ArticleId><ArticleId IdType="pmc">PMC3503026</ArticleId><ArticleId IdType="pubmed">23055549</ArticleId></ArticleIdList></Reference><Reference><Citation>Marasco WA, Sui J. The growth and potential of human antiviral monoclonal antibody therapeutics. Nat Biotechnol. 2007;25(12):1421&#x2013;1434. doi: 10.1038/nbt1363.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nbt1363</ArticleId><ArticleId IdType="pmc">PMC7097443</ArticleId><ArticleId IdType="pubmed">18066039</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X, Mao C, Ma S, Wang X, Sun Z, Yi Y, Guo M, Shen X, Sun L, Bi S. Generation of neutralizing monoclonal antibodies against enterovirus 71 using synthetic peptides. Biochem Biophys Res Commun. 2009;390(4):1126&#x2013;1128. doi: 10.1016/j.bbrc.2009.09.103.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2009.09.103</ArticleId><ArticleId IdType="pubmed">19799860</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang GH, Luo YJ, Wu XY, Si BY, Lin L, Zhu QY. Monoclonal antibody induced with inactived EV71-Hn2 virus protects mice against lethal EV71-Hn2 virus infection. Virol J. 2010;7:106. doi: 10.1186/1743-422X-7-106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1743-422X-7-106</ArticleId><ArticleId IdType="pmc">PMC2887433</ArticleId><ArticleId IdType="pubmed">20500892</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang HW, Liu CC, Lin MH, Ho HM, Yang YT, Chow YH, Chong P, Sia C. Generation of murine monoclonal antibodies which cross-neutralize human enterovirus genogroup B isolates. J Virol Methods. 2011;173(2):189&#x2013;195. doi: 10.1016/j.jviromet.2011.02.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jviromet.2011.02.003</ArticleId><ArticleId IdType="pubmed">21315763</ArticleId></ArticleIdList></Reference><Reference><Citation>Ku Z, Shi J, Liu Q, Huang Z. Development of murine monoclonal antibodies with potent neutralization effects on enterovirus 71. J Virol Methods. 2012;186(1&#x2013;2):193&#x2013;197. doi: 10.1016/j.jviromet.2012.06.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jviromet.2012.06.025</ArticleId><ArticleId IdType="pubmed">22771741</ArticleId></ArticleIdList></Reference><Reference><Citation>Xue J, Li Y, Xu X, Yu J, Yan H, Yan H. EV71 infection correlates with viral IgG preexisting at pharyngo-laryngeal mucosa in children. Virol Sin. 2015;30(2):1&#x2013;8. doi: 10.1007/s12250-014-3555-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12250-014-3555-2</ArticleId><ArticleId IdType="pmc">PMC8200873</ArticleId><ArticleId IdType="pubmed">25813631</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, Liu F, Han C, Yan H. Monoclonal antibody that blocks the toll-like receptor 5 binding region of flagellin. Hybridoma (Larchmt) 2012;31(1):60&#x2013;62. doi: 10.1089/hyb.2011.0083.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/hyb.2011.0083</ArticleId><ArticleId IdType="pmc">PMC3275795</ArticleId><ArticleId IdType="pubmed">22316487</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiener TK, Lim XF, Jia Q, Meng T, Chow VT, Kwang J. Characterization of a monoclonal antibody against the 3D polymerase of enterovirus 71 and its use for the detection of human enterovirus a infection. J Virol Methods. 2012;180(1&#x2013;2):75&#x2013;83. doi: 10.1016/j.jviromet.2011.12.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jviromet.2011.12.015</ArticleId><ArticleId IdType="pubmed">22226793</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Y, Lou Z, Miao Y, Yu Y, Dong H, Peng W, Bartlam M, Li X, Rao Z. Structures of EV71 RNA-dependent RNA polymerase in complex with substrate and analogue provide a drug target against the hand-foot-and-mouth disease pandemic in China. Protein Cell. 2010;1(5):491&#x2013;500. doi: 10.1007/s13238-010-0061-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13238-010-0061-7</ArticleId><ArticleId IdType="pmc">PMC4875138</ArticleId><ArticleId IdType="pubmed">21203964</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Z, Palaniyandi S, Zeng R, Tuo W, Roopenian DC, Zhu X. Transfer of IgG in the female genital tract by MHC class I-related neonatal fc receptor (FcRn) confers protective immunity to vaginal infection. Proc Natl Acad Sci U S A. 2011;108(11):4388&#x2013;4393. doi: 10.1073/pnas.1012861108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1012861108</ArticleId><ArticleId IdType="pmc">PMC3060240</ArticleId><ArticleId IdType="pubmed">21368166</ArticleId></ArticleIdList></Reference><Reference><Citation>Bidgood SR, Tam JC, McEwan WA, Mallery DL, James LC. Translocalized IgA mediates neutralization and stimulates innate immunity inside infected cells. Proc Natl Acad Sci U S A. 2014;111(37):13463&#x2013;13468. doi: 10.1073/pnas.1410980111.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1410980111</ArticleId><ArticleId IdType="pmc">PMC4169910</ArticleId><ArticleId IdType="pubmed">25169018</ArticleId></ArticleIdList></Reference><Reference><Citation>Li ZH, Li CM, Ling P, Shen FH, Chen SH, Liu CC, Yu CK. Ribavirin reduces mortality in enterovirus 71-infected mice by decreasing viral replication. J Infect Dis. 2008;197(6):854&#x2013;857. doi: 10.1086/527326.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/527326</ArticleId><ArticleId IdType="pmc">PMC7109938</ArticleId><ArticleId IdType="pubmed">18279075</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen TC, Chang HY, Lin PF, Chern JH, Hsu JT, Chang CY, Shih SR. Novel antiviral agent DTriP-22 targets RNA-dependent RNA polymerase of enterovirus 71. Antimicrob Agents Chemother. 2009;53(7):2740&#x2013;2747. doi: 10.1128/AAC.00101-09.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/AAC.00101-09</ArticleId><ArticleId IdType="pmc">PMC2704669</ArticleId><ArticleId IdType="pubmed">19414569</ArticleId></ArticleIdList></Reference><Reference><Citation>Urbinati C, Chiodelli P, Rusnati M. Polyanionic drugs and viral oncogenesis: a novel approach to control infection, tumor-associated inflammation and angiogenesis. Molecules. 2008;13(11):2758&#x2013;2785. doi: 10.3390/molecules13112758.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules13112758</ArticleId><ArticleId IdType="pmc">PMC6245429</ArticleId><ArticleId IdType="pubmed">19002078</ArticleId></ArticleIdList></Reference><Reference><Citation>Thueng-in K, Thanongsaksrikul J, Jittavisutthikul S, Seesuay W, Chulanetra M, Sakolvaree Y, Srimanote P, Chaicumpa W. Interference of HCV replication by cell penetrable human monoclonal scFv specific to NS5B polymerase. MAbs. 2014;6(5):1327&#x2013;1339. doi: 10.4161/mabs.29978.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/mabs.29978</ArticleId><ArticleId IdType="pmc">PMC4622650</ArticleId><ArticleId IdType="pubmed">25517317</ArticleId></ArticleIdList></Reference><Reference><Citation>Boonrod K, Galetzka D, Nagy PD, Conrad U, Krczal G. Single-chain antibodies against a plant viral RNA-dependent RNA polymerase confer virus resistance. Nat Biotechnol. 2004;22(7):856&#x2013;862. doi: 10.1038/nbt983.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nbt983</ArticleId><ArticleId IdType="pubmed">15195103</ArticleId></ArticleIdList></Reference><Reference><Citation>Ye X, Ku Z, Liu Q, Wang X, Shi J, Zhang Y, Kong L, Cong Y, Huang Z. Chimeric virus-like particle vaccines displaying conserved enterovirus 71 epitopes elicit protective neutralizing antibodies in mice through divergent mechanisms. J Virol. 2014;88(1):72&#x2013;81. doi: 10.1128/JVI.01848-13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01848-13</ArticleId><ArticleId IdType="pmc">PMC3911748</ArticleId><ArticleId IdType="pubmed">24131712</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu G, Gong P. Crystal structure of the full-length Japanese encephalitis virus NS5 reveals a conserved methyltransferase-polymerase interface. PLoS Pathog. 2013;9(8):e1003549. doi: 10.1371/journal.ppat.1003549.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1003549</ArticleId><ArticleId IdType="pmc">PMC3738499</ArticleId><ArticleId IdType="pubmed">23950717</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, Hou L, Ye J, Liu X, Dan H, Jin M, Chen H, Cao S. Development of a convenient immunochromatographic strip for the diagnosis of infection with Japanese encephalitis virus in swine. J Virol Methods. 2010;168(1&#x2013;2):51&#x2013;56. doi: 10.1016/j.jviromet.2010.04.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jviromet.2010.04.015</ArticleId><ArticleId IdType="pubmed">20433870</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang J, Zhang E, Liu F, Zhang Y, Zhong M, Li Y, Zhou D, Chen Y, Cao Y, Xiao Y, et al. Flagellins of Salmonella Typhi and nonpathogenic Escherichia coli are differentially recognized through the NLRC4 pathway in macrophages. J Innate Immun. 2014;6(1):47&#x2013;57. doi: 10.1159/000351476.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000351476</ArticleId><ArticleId IdType="pmc">PMC6741629</ArticleId><ArticleId IdType="pubmed">23816851</ArticleId></ArticleIdList></Reference><Reference><Citation>Shang B, Deng C, Ye H, Xu W, Yuan Z, Shi PY, Zhang B. Development and characterization of a stable eGFP enterovirus 71 for antiviral screening. Antivir Res. 2013;97(2):198&#x2013;205. doi: 10.1016/j.antiviral.2012.12.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2012.12.010</ArticleId><ArticleId IdType="pubmed">23267829</ArticleId></ArticleIdList></Reference><Reference><Citation>Gong P, Peersen OB. Structural basis for active site closure by the poliovirus RNA-dependent RNA polymerase. Proc Natl Acad Sci U S A. 2010;107(52):22505&#x2013;22510. doi: 10.1073/pnas.1007626107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1007626107</ArticleId><ArticleId IdType="pmc">PMC3012486</ArticleId><ArticleId IdType="pubmed">21148772</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>